Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sphenoidal pituitary adenoma.

A Borit, T P Blanshard

    Human Pathology
    |January 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    A 62-year-old female presented with a rare chromophobe pituitary adenoma. She also had multiple endocrine neoplasia syndrome, including parathyroid, thyroid, and ovarian tumors.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Metastatic renal cell carcinoma simulating glomus jugulare tumor.

    Journal of surgical oncology·1987
    Same author

    Central neural antigens: detection and diagnostic application.

    Critical reviews in clinical laboratory sciences·1986
    Same author

    High dose Ara-C related leukoencephalopathy.

    Journal of neuro-oncology·1986
    Same author

    The endocrine glands in Pompe's disease. Report of two cases.

    Archives of pathology & laboratory medicine·1985
    Same author

    Vimentin and glial fibrillary acidic protein in human brain tumors.

    Journal of neuro-oncology·1985
    Same author

    A rabbit model of intracerebral hematoma.

    Acta neuropathologica·1985
    Same journal

    TRPS1 and GATA3 Expression in BRG1/SMARCA4-deficient Malignant Neoplasms.

    Human pathology·2026
    Same journal

    Clinicopathologic and Molecular Characteristics of Acral Melanomas Harboring RARA Fusions.

    Human pathology·2026
    Same journal

    Clinical Impact of Second Opinion Consultation in Bladder Biopsies and Transurethral Resection of Bladder Tumors.

    Human pathology·2026
    Same journal

    Prognostic relevance and molecular correlates of Claudin-1 expression in pancreatic neuroendocrine tumors.

    Human pathology·2026
    Same journal

    Mixed Phenotype Acute Leukemia: Lineage Assignment, Immunophenotypic Classification and Genetic Insights.

    Human pathology·2026
    Same journal

    Chronic myelomonocytic leukemia revisited: A comprehensive review with emphasis on the oligomonocytic subtype.

    Human pathology·2026
    See all related articles

    Area of Science:

    • Endocrinology
    • Oncology
    • Pathology

    Background:

    • Pituitary adenomas are common tumors, but chromophobe adenomas are less frequent.
    • Multiple Endocrine Neoplasia (MEN) syndromes are rare genetic disorders characterized by tumors in endocrine glands.

    Observation:

    • A 62-year-old female patient was diagnosed with a chromophobe pituitary adenoma originating from the sphenoid bone.
    • A normal pituitary gland was found within the sella turcica, distinct from the adenoma.
    • The patient also exhibited a chief cell parathyroid adenoma, papillary thyroid carcinoma, and an ovarian thecoma.

    Findings:

    • The co-occurrence of pituitary adenoma with parathyroid, thyroid, and ovarian tumors suggests a potential underlying genetic predisposition.
    • The pathological findings are consistent with a diagnosis of Multiple Endocrine Neoplasia (MEN) syndrome, although the specific subtype requires further genetic analysis.

    Related Experiment Videos

  • The anatomical location of the pituitary adenoma in the sphenoid bone is noted.
  • Implications:

    • This case highlights the importance of comprehensive endocrine and oncological evaluation in patients with pituitary tumors.
    • Understanding the genetic basis of MEN syndromes is crucial for early diagnosis, genetic counseling, and personalized treatment strategies.
    • Further research into the specific genetic mutations and molecular pathways involved in such complex endocrine tumor presentations is warranted.